A Tasmanian researcher has been awarded one of the highest honours for his work in advancing respiratory health in Australia and New Zealand.
Dr Sukhwinder Sohal (Romy) was recently recognised as a Fellow of the Thoracic Society of Australia and New Zealand (TSANZ,FThorSoc) for his contributions and commitment to respiratory medicine over the past two decades.
Dr Sohal is a senior lecturer in the University’s School of Health Sciences and a leading expert in lung disease, particularly chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and effects of smoking and vaping.
“I am extremely humbled to receive such a prestigious award, which not only recognises my work, but also all of my students, postdocs, collaborators and colleagues in the field,” Dr Sohal said.
“Our work has helped to pioneer research into lung disease and this award reflects the hard work and dedication by the team.”
The TSANZ is the peak body of Australia and New Zealand representing respiratory and sleep medicine.
The Thoracic Society also recognised Dr Sohals’ commitment to support next generation of respiratory researchers by initiating “Sukhdev Singh Sohal COPD Research Award” in memory of his late father. This PhD scholarship is funded through donations from the Sohal Family and supported through collaboration between the TSANZ and Lung Foundation Australia.
This isn’t the first time Dr Sohal’s work has been nominated by his peers.
In 2016 he was recognised as a Fellow of the Asian Pacific Society of Respirology (FAPSR) for his contributions to lung health and continues to provide his expertise to the World Health Organisation (WHO) and collaborate with the Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD). He has published with WHO and members from GOLD and GINA informing global policy and community. For his work on mechanisms leading to COPD and lung cancer, he was recognised with Innovative Science and Technology Award 2016, presented by the Australian Government, Department of Industry, Innovation and Science.
In 2021, Dr Sohal was one of three panel experts invited by the European Respiratory Society (ERS) to participate in a live discussion, presented on the ERS Respiratory Channel, on ‘Smoking and COVID19 – what have we learned?’ This was streamed live to the entire respiratory community of the world.
He was also invited by the Asian Pacific Society of Respirology (APSR) to chair the committee of respiratory experts from different parts of the world to put together a joint statement on the risk of COVID-19 in patients with COPD for the Asia Pacific region. This statement was published in the Journal of Clinical Medicine.